[1P-0639] Combinational treatment of the p53 activator and the CDK8 inhibitor induces cell death in neuroblastomas

〇Ayana Nakajima^1,2, Makoto Miyazaki^1,3, Yuko Hibiya¹, Arata Tomiyama^1,4, Tetsuro Kokubo², Koichi Ichimura¹ (1.Div. Brain Tumor Translational Res., Natl. Cancer Ctr. Res. Inst., 2.Grad. Sch. of Med. Life Sci. Yokohama City Univ., 3.Dept. of Cancer Cell Res., Sasaki Inst., Sasaki Foundation, 4.Dept. Neurosurg. Natl. Def. Med. Col.)

Neuroblastoma, p53, CDK8, Molecular target drug, Cell death